Role of QuantiFERON-TB gold, interferon gamma inducible protein-10 and tuberculin skin test in active tuberculosis diagnosis

PLoS ONE

Volumn 5, Issue 2, 2010, Pages

  Syed Ahamed Kabeer, Basirudeen ^a   Raman, Balambal ^a   Thomas, Aleyamma ^a   Perumal, Venkatesan ^a   Raja, Alamelu ^a  

^a NATIONAL INSTITUTE FOR RESEARCH IN TUBERCULOSIS   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; GAMMA INTERFERON INDUCIBLE PROTEIN 10; TUBERCULOSTATIC AGENT;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; LUNG DISEASE; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; QUANTITATIVE ASSAY; SENSITIVITY AND SPECIFICITY; SPUTUM SMEAR; TUBERCULIN TEST;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HIV SERONEGATIVITY; HUMANS; INTERFERON-GAMMA; LATENT TUBERCULOSIS; MALE; MIDDLE AGED; PYRIMIDINONES; REAGENT KITS, DIAGNOSTIC; SENSITIVITY AND SPECIFICITY; THIAZOLES; TUBERCULIN TEST; YOUNG ADULT;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 77949348559     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0009051     Document Type: Article

References (45)

1. World Health Organization (2008) Global tuberculosis control- surveillance, planning, financing. Geneva. WHO/HTM/TB/2008.393.
2. Brodie D, Schluger NW (2005) The diagnosis of tuberculosis. Clin Chest Med 26: 247-271.
3. Pai M, Kalantri S, Dheda K (2006) New tools and emerging technologies for the diagnosis of tuberculosis: part II. Active tuberculosis and drug resistance. Expert Rev Mol Diagn 6: 423-432.
4. Pai M, Kalantri S, Menzies D (2006) Discordance between tuberculin skin test and interferon-gamma assays. Int J Tuberc Lung Dis 10: 942-943.
5. Detjen AK, Keil T, Roll S, Hauer B, Mauch H, et al. (2007) Interferon-gamma release assays improve the diagnosis of tuberculosis and nontuberculous mycobacterial disease in children in a country with a low incidence of tuberculosis. Clin Infect Dis 45: 322-328.
6. Dominguez J, Ruiz-Manzano J, De Souza-Galvao M, Latorre I, Mila C, et al. (2008) Comparison of two commercially available gamma interferon blood tests for immunodiagnosis of tuberculosis. Clin Vaccine Immunol 15: 168-171.
7. Palazzo R, Spensieri F, Massari M, Fedele G, Frasca L, et al. (2008) Use of whole-blood samples in in-house bulk and single-cell antigen-specific gamma interferon assays for surveillance of Mycobacterium tuberculosis infections. Clin Vaccine Immunol 15: 327-337.
8. Chee CB, Gan SH, Khinmar KW, Barkham TM, Koh CK, et al. (2008) Comparison of sensitivities of two commercial gamma interferon release assays for pulmonary tuberculosis. J Clin Microbiol 46: 1935-1940.
9. Bartu V, Havelkova M, Kopecka E (2008) QuantiFERON-TB Gold in the diagnosis of active tuberculosis. J Int Med Res 36: 434-437.
10. Harada N, Higuchi K, Yoshiyama T, Kawabe Y, Fujita A, et al. (2008) Comparison of the sensitivity and specificity of two whole blood interferon-gamma assays for M. tuberculosis infection. J Infect 56: 348-353.
11. Ruhwald M, Bodmer T, Maier C, Jepsen M, Haaland MB, et al. (2008) Evaluating the potential of IP-10 and MCP-2 as biomarkers for the diagnosis of tuberculosis. Eur Respir J 32: 1607-1615.
12. Dosanjh DP, Hinks TS, Innes JA, Deeks JJ, Pasvol G, et al. (2008) Improved diagnostic evaluation of suspected tuberculosis. Ann Intern Med 148: 325-336.
13. Tsiouris SJ, Coetzee D, Toro PL, Austin J, Stein Z, et al. (2006) Sensitivity analysis and potential uses of a novel gamma interferon release assay for diagnosis of tuberculosis. J Clin Microbiol 44: 2844-2850.
14. Adetifa IM, Lugos MD, Hammond A, Jeffries D, Donkor S, et al. (2007) Comparison of two interferon gamma release assays in the diagnosis of Mycobacterium tuberculosis infection and disease in The Gambia. BMC Infect Dis 7: 122.
15. Pai M, Joshi R, Bandyopadhyay M, Narang P, Dogra S, et al. (2007) Sensitivity of a whole-blood interferon-gamma assay among patients with pulmonary tuberculosis and variations in T-cell responses during anti-tuberculosis treatment. Infection 35: 98-103.
16. Raby E, Moyo M, Devendra A, Banda J, De Haas P, et al. (2008) The effects of HIV on the sensitivity of a whole blood IFN-gamma release assay in Zambian adults with active tuberculosis. PLoS One 3: e2489.
17. Ruhwald M, Bjerregaard-Andersen M, Rabna P, Kofoed K, Eugen-Olsen J, et al. (2007) CXCL10/IP-10 release is induced by incubation of whole blood from tuberculosis patients with ESAT-6, CFP10 and TB7.7. Microbes Infect 9: 806-812.
18. Whittaker E, Gordon A, Kampmann B (2008) Is IP-10 a better biomarker for active and latent tuberculosis in children than IFNgamma? PLoS One 3: e3901.
19. Dheda K, Van-Zyl Smit RN, Sechi LA, Badri M, Meldau R, et al. (2009) Clinical diagnostic utility of IP-10 and LAM antigen levels for the diagnosis of tuberculous pleural effusions in a high burden setting. PLoS One 4: e4689.
20. Lighter J, Rigaud M, Eduardo R, Peng CH, Pollack H (2009) Latent tuberculosis diagnosis in children by using the QuantiFERON-TB Gold In-Tube test. Pediatrics 123: 30-37.
21. Moser B, Loetscher P (2001) Lymphocyte traffic control by chemokines. Nat Immunol 2: 123-128.
22. Dhillon NK, Peng F, Ransohoff RM, Buch S (2007) PDGF synergistically enhances IFN-gamma-induced expression of CXCL10 in blood-derived macrophages: implications for HIV dementia. J Immunol 179: 2722-2730.
23. Ragno S, Romano M, Howell S, Pappin DJ, Jenner PJ, et al. (2001) Changes in gene expression in macrophages infected with Mycobacterium tuberculosis: a combined transcriptomic and proteomic approach. Immunology 104: 99-108.
24. Samson KT, Minoguchi K, Tanaka A, Oda N, Yokoe T, et al. (2006) Inhibitory effects of fluvastatin on cytokine and chemokine production by peripheral blood mononuclear cells in patients with allergic asthma. Clin Exp Allergy 36: 475-482.
25. World Health Organization (2008) Global TB data base: TB County Profile-India.
26. Selvakumar N, Gomathi Sekar M, Kumar V, Bhaskar Rao DV, Rahman F, et al. (2006) Sensitivity of Ziehl-Neelsen method for centrifuged deposit smears of sputum samples transported in cetyl-pyridinium chloride. Indian J Med Res 124: 439-442.
27. Central TB Division, Directorate General of Health Services, Ministry of Health and Family Welfare (1998) Revised National Tuberculosis Control Programme manual for laboratory technicians. Ministry of Health and Family Welfare, New Delhi, India. Available: http://www.tbcindia.org/LABMANUAL.pdf.
28. Ramachandran G, Hemanthkumar AK, Rajasekaran S, Padmapriyadarsini C, Narendran G, et al. (2007) Steady-State Pharmacokinetics of Nevirapine in HIV-1 Infected Adults in India. J Int Assoc Physicians AIDS Care (Chic Ill) 6: 251-254.
29. Kabeer BS, Sikhamani R, Raja A (2010) Comparison of interferon gamma and interferon gamma-inducible protein-10 secretion in HIV-tuberculosis patients. Aids 24: 323-325.
30. Seah GT, Scott GM, Rook GA (2000) Type 2 cytokine gene activation and its relationship to extent of disease in patients with tuberculosis. J Infect Dis 181: 385-389.
31. Dheda K, Smit RZ, Badri M, Pai M (2009) T-cell interferon-gamma release assays for the rapid immunodiagnosis of tuberculosis: clinical utility in high-burden vs. low-burden settings. Curr Opin Pulm Med 15: 188-200.
32. Lagrange PH, Herrmann JL (2008) Diagnosing Latent Tuberculosis Infection in the HIV Era. Open Respir Med J 2: 52-59.
33. Syed Ahamed Kabeer B, Sikhamani R, Swaminathan S, Perumal V, Paramasivam P, et al. (2009) Role of interferon gamma release assay in active TB diagnosis among HIV infected individuals. PLoS One 4: e5718.
34. Rajavelu P, Das SD (2005) Th2-type immune response observed in healthy individuals to sonicate antigen prepared from the most prevalent Mycobacterium tuberculosis strain with single copy of IS6110. FEMS Immunol Med Microbiol 45: 95-102.
35. Okamoto M, Kawabe T, Iwasaki Y, Hara T, Hashimoto N, et al. (2005) Evaluation of interferon-gamma, interferon-gamma-inducing cytokines, and interferon-gamma-inducible chemokines in tuberculous pleural effusions. J Lab Clin Med 145: 88-93.
36. Azzurri A, Sow OY, Amedei A, Bah B, Diallo S, et al. (2005) IFN-gamma-inducible protein 10 and pentraxin 3 plasma levels are tools for monitoring inflammation and disease activity in Mycobacterium tuberculosis infection. Microbes Infect 7: 1-8.
37. Juffermans NP, Verbon A, van Deventer SJ, van Deutekom H, Belisle JT, et al. (1999) Elevated chemokine concentrations in sera of human immunodeficiency virus (HIV)-seropositive and HIV-seronegative patients with tuberculosis: a possible role for mycobacterial lipoarabinomannan. Infect Immun 67: 4295-4297.
38. Sodhi A, Gong J, Silva C, Qian D, Barnes PF (1997) Clinical correlates of interferon gamma production in patients with tuberculosis. Clin Infect Dis 25: 617-620.
39. Wu HP, Hua CC, Chuang DY (2007) Decreased in vitro interferon-gamma production in patients with cavitary tuberculosis on chest radiography. Respir Med 101: 48-52.
40. Yamashiro S, Kawakami K, Uezu K, Kinjo T, Miyagi K, et al. (2005) Lower expression of Th1-related cytokines and inducible nitric oxide synthase in mice with streptozotocin-induced diabetes mellitus infected with Mycobacterium tuberculosis. Clin Exp Immunol 139: 57-64.
41. Tsukaguchi K, Okamura H, Matsuzawa K, Tamura M, Miyazaki R, et al. (2002) [Longitudinal assessment of IFN-gamma production in patients with pulmonary tuberculosis complicated with diabetes mellitus]. Kekkaku 77: 409-413.
42. Pai M, Riley LW, Colford JM Jr (2004) Interferon-gamma assays in the immunodiagnosis of tuberculosis: a systematic review. Lancet Infect Dis 4: 761-776.
43. Markowitz N, Hansen NI, Hopewell PC, Glassroth J, Kvale PA, et al. (1997) Incidence of tuberculosis in the United States among HIV-infected persons. The Pulmonary Complications of HIV Infection Study Group. Ann Intern Med 126: 123-132.
44. National AIDS Control Organization (2007) Operational Guidelines for Integrated counseling and testing centre.
45. Steinbrook R (2007) Tuberculosis and HIV in India. N Engl J Med 356: 1198-1199.